Technically speaking this isn't true, it is a requirement of clinical evaluation and risk analysis by European regulations. The key difference is that European regulators look a lot less closely at the actual clinical data, and more closely at the evaluation process used by manufacturers.
- Forums
- ASX - By Stock
- RAP
- RAP media thread.
RAP media thread., page-1639
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1,758 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)